Trial intelligence / Profile preview

Minoxidil for Repigmentation of White Hair

NCT06813963Phase 4Completed

Sponsor
Southern Medical University
Start
Feb 2025
Primary completion
Feb 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in canities comparing 5% minoxidil group with Placebo Group (2 arms). Primary endpoint: Reduction in the appearance gray hair grade at 12 months. Started Feb 2025; status: completed.

02

Drugs

minoxidil
03

Conditions

canities

Beyond the preview

Go deeper on NCT06813963.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06813963.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call